Free Trial
NASDAQ:SERA

Sera Prognostics (SERA) Stock Price, News & Analysis

Sera Prognostics logo
$2.50 +0.05 (+1.84%)
Closing price 07/3/2025 03:53 PM Eastern
Extended Trading
$2.55 +0.05 (+2.20%)
As of 07/3/2025 04:49 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Sera Prognostics Stock (NASDAQ:SERA)

Key Stats

Today's Range
$2.37
$2.49
50-Day Range
$1.49
$4.09
52-Week Range
$1.37
$9.13
Volume
80,123 shs
Average Volume
178,407 shs
Market Capitalization
$93.99 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Sera Prognostics Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
28th Percentile Overall Score

SERA MarketRank™: 

Sera Prognostics scored higher than 28% of companies evaluated by MarketBeat, and ranked 2425th out of 2,814 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Sera Prognostics.

  • Earnings Growth

    Earnings for Sera Prognostics are expected to decrease in the coming year, from ($0.96) to ($0.98) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Sera Prognostics is -2.65, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Sera Prognostics is -2.65, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Sera Prognostics has a P/B Ratio of 1.78. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Sera Prognostics' valuation and earnings.
  • Percentage of Shares Shorted

    3.75% of the float of Sera Prognostics has been sold short.
  • Short Interest Ratio / Days to Cover

    Sera Prognostics has a short interest ratio ("days to cover") of 4.2.
  • Change versus previous month

    Short interest in Sera Prognostics has recently decreased by 13.39%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Sera Prognostics does not currently pay a dividend.

  • Dividend Growth

    Sera Prognostics does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    3.75% of the float of Sera Prognostics has been sold short.
  • Short Interest Ratio / Days to Cover

    Sera Prognostics has a short interest ratio ("days to cover") of 4.2.
  • Change versus previous month

    Short interest in Sera Prognostics has recently decreased by 13.39%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Sera Prognostics has a news sentiment score of 0.72. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.54 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Sera Prognostics this week, compared to 1 article on an average week.
  • Search Interest

    5 people have searched for SERA on MarketBeat in the last 30 days. This is an increase of 400% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Sera Prognostics insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $127,856.00 in company stock.

  • Percentage Held by Insiders

    13.50% of the stock of Sera Prognostics is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    54.64% of the stock of Sera Prognostics is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Sera Prognostics' insider trading history.
Receive SERA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sera Prognostics and its competitors with MarketBeat's FREE daily newsletter.

SERA Stock News Headlines

379 passengers walked away from this
Why Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT Scientists
See More Headlines

SERA Stock Analysis - Frequently Asked Questions

Sera Prognostics' stock was trading at $8.14 at the beginning of 2025. Since then, SERA stock has decreased by 69.3% and is now trading at $2.4950.

Sera Prognostics, Inc. (NASDAQ:SERA) announced its quarterly earnings results on Wednesday, May, 14th. The company reported ($0.20) EPS for the quarter, beating the consensus estimate of ($0.24) by $0.04. The company earned $0.04 million during the quarter, compared to analyst estimates of $0.06 million. Sera Prognostics had a negative trailing twelve-month return on equity of 51.35% and a negative net margin of 28,685.22%.
Read the conference call transcript
.

Sera Prognostics (SERA) raised $75 million in an IPO on Thursday, July 15th 2021. The company issued 4,687,500 shares at $15.00-$17.00 per share.

Shares of SERA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Sera Prognostics investors own include Meta Platforms (META), JPMorgan Chase & Co. (JPM), Tesla (TSLA), NVIDIA (NVDA), Netflix (NFLX), Advanced Micro Devices (AMD) and Home Depot (HD).

Company Calendar

Last Earnings
5/14/2025
Today
7/03/2025
Next Earnings (Estimated)
8/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Medical Services
Sub-Industry
Healthcare
Current Symbol
NASDAQ:SERA
Fax
N/A
Employees
120
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$32.90 million
Net Margins
-28,685.22%
Pretax Margin
-28,685.22%

Debt

Sales & Book Value

Annual Sales
$80 thousand
Price / Cash Flow
N/A
Book Value
$1.40 per share
Price / Book
1.78

Miscellaneous

Free Float
32,587,000
Market Cap
$93.99 million
Optionable
Optionable
Beta
0.99
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

This page (NASDAQ:SERA) was last updated on 7/4/2025 by MarketBeat.com Staff
From Our Partners